Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Velan Capital Investment Management LP (CIK 1848809) reported $159.6M across 46 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: PRAX ($32.5M, 20.34%), TARA ($14.8M, 9.25%), STRO ($12.8M, 7.99%), ($10.3M, 6.43%), ($10.0M, 6.28%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | PRAX | PRAXIS PRECISION MEDICINES I | $32.5M | 20.34% | 100,781 | Hold |
| 2 | TARA | PROTARA THERAPEUTICS INC | $14.8M | 9.25% | 2.8M | Hold |
| 3 | STRO | SUTRO BIOPHARMA INC | $12.8M | 7.99% | 512,160 | Added |
| 4 | EVOMMUNE INC | $10.3M | 6.43% | 446,255 | Trimmed | |
| 5 | MAPLIGHT THERAPEUTICS INC | $10.0M | 6.28% | 492,893 | Trimmed | |
| 6 | TENX | TENAX THERAPEUTICS INC | $9.3M | 5.84% | 583,333 | Added |
| 7 | ABVX | ABIVAX SA | $8.6M | 5.37% | 77,000 | Added |
| 8 | HRTX | HERON THERAPEUTICS INC | $7.0M | 4.39% | 8.8M | Hold |
| 9 | IMMX | IMMIX BIOPHARMA INC | $6.7M | 4.22% | 740,000 | Added |
| 10 | ESPR | ESPERION THERAPEUTICS INC NE | $4.7M | 2.95% | 1.7M | Added |
| 11 | EDSA | EDESA BIOTECH INC | $4.3M | 2.71% | 827,500 | Added |
| 12 | AVR | ANTERIS TECHNOLOGIES GLOBAL | $3.9M | 2.43% | 700,000 | New |
| 13 | NSPR | INSPIREMD INC | $3.4M | 2.14% | 2.1M | Trimmed |
| 14 | XNCR | XENCOR INC | $3.0M | 1.89% | 250,000 | New |
| 15 | AVTX | AVALO THERAPEUTICS INC | $2.8M | 1.73% | 185,122 | Trimmed |
| 16 | EPRX | EUPRAXIA PHARMACEUTICALS INC | $2.5M | 1.60% | 352,000 | Hold |
| 17 | CTMX | CYTOMX THERAPEUTICS INC. | $2.5M | 1.59% | 540,000 | Added |
| 18 | VRCA | VERRICA PHARMACEUTICALS INC | $2.5M | 1.56% | 471,559 | Hold |
| 19 | JSPR | JASPER THERAPEUTICS INC | $2.3M | 1.46% | 2.7M | Hold |
| 20 | RZLT | REZOLUTE INC | $2.3M | 1.43% | 750,000 | Hold |
| 21 | LYEL | LYELL IMMUNOPHARMA INC | $2.0M | 1.28% | 102,000 | New |
| 22 | PROF | PROFOUND MED CORP | $1.9M | 1.16% | 285,710 | Hold |
| 23 | VRDN | VIRIDIAN THERAPEUTICS INC | $1.8M | 1.12% | 91,123 | Added |
| 24 | RCKT | ROCKET PHARMACEUTICALS INC | $1.1M | 0.66% | 294,643 | New |
| 25 | KZIA | KAZIA THERAPEUTICS LTD | $1.0M | 0.63% | 135,315 | Trimmed |
Source: SEC Form 13F filings · as of 2026-03-31